For Industry

Public Meeting on Patient-Focused Drug Development

On October 25, 2012, FDA held a public meeting to begin the agency's patient-focused drug development initiative. This initiative is being conducted to fulfill FDA performance commitments made as part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V).   

Page Last Updated: 05/05/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.